193 related articles for article (PubMed ID: 29245982)
1. Endothelial-derived interleukin-6 induces cancer stem cell motility by generating a chemotactic gradient towards blood vessels.
Kim HS; Chen YC; Nör F; Warner KA; Andrews A; Wagner VP; Zhang Z; Zhang Z; Martins MD; Pearson AT; Yoon E; Nör JE
Oncotarget; 2017 Nov; 8(59):100339-100352. PubMed ID: 29245982
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.
Nör C; Zhang Z; Warner KA; Bernardi L; Visioli F; Helman JI; Roesler R; Nör JE
Neoplasia; 2014 Feb; 16(2):137-46. PubMed ID: 24709421
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells.
Krishnamurthy S; Dong Z; Vodopyanov D; Imai A; Helman JI; Prince ME; Wicha MS; Nör JE
Cancer Res; 2010 Dec; 70(23):9969-78. PubMed ID: 21098716
[TBL] [Abstract][Full Text] [Related]
4. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE
Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319
[TBL] [Abstract][Full Text] [Related]
5. Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells.
Krishnamurthy S; Warner KA; Dong Z; Imai A; Nör C; Ward BB; Helman JI; Taichman RS; Bellile EL; McCauley LK; Polverini PJ; Prince ME; Wicha MS; Nör JE
Stem Cells; 2014 Nov; 32(11):2845-57. PubMed ID: 25078284
[TBL] [Abstract][Full Text] [Related]
6. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells.
Herzog AE; Warner KA; Zhang Z; Bellile E; Bhagat MA; Castilho RM; Wolf GT; Polverini PJ; Pearson AT; Nör JE
Cell Death Dis; 2021 Oct; 12(11):988. PubMed ID: 34689150
[TBL] [Abstract][Full Text] [Related]
7. Endothelial derived factors inhibit anoikis of head and neck cancer stem cells.
Campos MS; Neiva KG; Meyers KA; Krishnamurthy S; Nör JE
Oral Oncol; 2012 Jan; 48(1):26-32. PubMed ID: 22014666
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells in head and neck squamous cell carcinoma: a review.
Satpute PS; Hazarey V; Ahmed R; Yadav L
Asian Pac J Cancer Prev; 2013; 14(10):5579-87. PubMed ID: 24289547
[TBL] [Abstract][Full Text] [Related]
9. Head and neck cancer stem cells.
Krishnamurthy S; Nör JE
J Dent Res; 2012 Apr; 91(4):334-40. PubMed ID: 21933937
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype.
Zhang Z; Dong Z; Lauxen IS; Filho MS; Nör JE
Cancer Res; 2014 May; 74(10):2869-81. PubMed ID: 24686166
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
12. The biology of head and neck cancer stem cells.
Zhang Z; Filho MS; Nör JE
Oral Oncol; 2012 Jan; 48(1):1-9. PubMed ID: 22070916
[TBL] [Abstract][Full Text] [Related]
13. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
Kerk SA; Finkel KA; Pearson AT; Warner KA; Zhang Z; Nör F; Wagner VP; Vargas PA; Wicha MS; Hurt EM; Hollingsworth RE; Tice DA; Nör JE
Clin Cancer Res; 2017 May; 23(10):2516-2527. PubMed ID: 27780858
[No Abstract] [Full Text] [Related]
14. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S
Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
17. ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas.
Huang C; Yoon C; Zhou XH; Zhou YC; Zhou WW; Liu H; Yang X; Lu J; Lee SY; Huang K
Cell Death Dis; 2020 Apr; 11(4):266. PubMed ID: 32327629
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
[TBL] [Abstract][Full Text] [Related]
19. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma.
Wu D; Cheng J; Sun G; Wu S; Li M; Gao Z; Zhai S; Li P; Su D; Wang X
Oncotarget; 2016 Jun; 7(24):36539-36550. PubMed ID: 27174914
[TBL] [Abstract][Full Text] [Related]
20. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]